Skip to main content
RZLT
NASDAQ Life Sciences

Rezolute Reports Q3 Net Loss of $16.17 Million, EPS -$0.16

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$3.3
Mkt Cap
$315.802M
52W Low
$1.07
52W High
$11.457
52W Position info
208% above low
Off High info
71% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

RZLT has more than doubled off its 52-week low of $1.07.

Summary

Rezolute reported a Q3 net loss of $16.17 million, translating to an EPS of -$0.16, with operating expenses reaching $17.37 million. These financial results indicate continued significant cash burn and losses for the company. While the company recently announced positive expanded results from its Phase 3 sunRIZE study, these Q3 figures highlight the ongoing financial challenges. This update follows the previous 10-Q which also indicated a wider net loss. Traders will be closely watching for further updates on the commercialization strategy for its drug candidates and any future financing activities to support its operations.

At the time of this announcement, RZLT was trading at $3.30 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $315.8M. The 52-week trading range was $1.07 to $11.46. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

RZLT - Latest Insights

RZLT
Nov 13, 2026, 12:27 PM EST
Source: Benzinga
Importance Score:
8
Price at Filing: $3.81
Real-time Price: $4.29 info
Change: +$0.485 (+13%) info
Market Cap: $411.098M info
RZLT
Nov 13, 2026, 6:26 AM EST
Filing Type: FWP
Importance Score:
8
Price at Filing: $4.19
Real-time Price: $4.29 info
Change: +$0.100 (+2%) info
Market Cap: $411.098M info
RZLT
Nov 13, 2026, 6:19 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $4.09
Real-time Price: $4.29 info
Change: +$0.200 (+5%) info
Market Cap: $411.098M info
RZLT
Nov 13, 2026, 6:18 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.91
Real-time Price: $4.29 info
Change: +$0.380 (+10%) info
Market Cap: $411.098M info
RZLT
Nov 13, 2026, 6:15 AM EST
Filing Type: 424B5
Importance Score:
7
Price at Filing: $3.87
Real-time Price: $4.29 info
Change: +$0.420 (+11%) info
Market Cap: $411.098M info